Live, queryable views of official open data — refreshed automatically, transparent about their sources, free to use. Two are live today, tracking oncology drug approvals and cancer clinical trials worldwide.
Every new oncology & haematology drug approval from the FDA and EMA, 2016 to today. Filter by tumour stream or medicine, and compare FDA vs EMA approvals side by side — the clearest view of how the two regulators diverge. Official open data, refreshed weekly.
Interventional oncology trials worldwide, first-registered within the last three years, from ClinicalTrials.gov. Filter by therapy type, sponsor, phase, status, tumour stream, country and trial design, and open any row for its primary and key secondary endpoints. Refreshed monthly.
Each tracker is built directly from official open data — the FDA and EMA registers, ClinicalTrials.gov — is transparent about its sources, and updates itself on a schedule. No scraping, no black boxes. Looking for our own analytical tools instead? They live under Tools.
Suggest a tracker